Watanabe, Ryo, Suzuki, Jun-ichi, Wakayama, Kouji, Maejima, Yasuhiro, Shimamura, Munehisa, Koriyama, Hiroshi, Nakagami, Hironori, Kumagai, Hidetoshi, Ikeda, Yuichi, Akazawa, Hiroshi, Morishita, Ryuichi, Komuro, Issei, Isobe, Mitsuaki (2017) A peptide vaccine targeting angiotensin II attenuates the cardiac dysfunction induced by myocardial infarction. Scientific Reports, 7. doi:10.1038/srep43920

See Also

These are possibly similar items as determined by title/reference text matching only.

	Kurinami, Hitomi, Shimamura, Munehisa, Nakagami, Hironori, Shimizu, Hideo, Koriyama, Hiroshi, Kawano, Tomohiro, Wakayama, Kouji, Mochizuki, Hideki, Rakugi, Hiromi, Morishita, Ryuichi (2016) A Novel Therapeutic Peptide as a Partial Agonist of RANKL in Ischemic Stroke. Scientific Reports, 6. doi:10.1038/srep38062
	Kyutoku, Mariko, Nakagami, Hironori, Koriyama, Hiroshi, Tomioka, Hideki, Nakagami, Futoshi, Shimamura, Munehisa, Kurinami, Hitomi, Zhengda, Pang, Jo, Dong Hyun, Kim, Jeong Hun, Takakura, Nobuyuki, Morishita, Ryuichi (2013) Development of novel DNA vaccine for VEGF in murine cancer model. Scientific Reports, 3. doi:10.1038/srep03380
	Kyutoku, Mariko, Nakagami, Hironori, Koriyama, Hiroshi, Nakagami, Futoshi, Shimamura, Munehisa, Kurinami, Hitomi, Tomioka, Hideki, Miyake, Takashi, Katsuya, Tomohiro, Morishita, Ryuichi (2013) Inhibition of Neointima Formation through DNA Vaccination for Apolipoprotein(a): A New Therapeutic Strategy for Lipoprotein(a). Scientific Reports, 3. doi:10.1038/srep01600
	Pang, Zhengda, Nakagami, Hironori, Osako, Mariana K., Koriyama, Hiroshi, Nakagami, Futoshi, Tomioka, Hideki, Shimamura, Munehisa, Kurinami, Hitomi, Takami, Yoichi, Morishita, Ryuichi, Rakugi, Hiromi (2014) Therapeutic vaccine against DPP4 improves glucose metabolism in mice. Proceedings of the National Academy of Sciences, 111 (13) doi:10.1073/pnas.1322009111
	Ju, Nan, Hayashi, Hiroki, Shimamura, Munehisa, Baba, Satoshi, Yoshida, Shota, Morishita, Ryuichi, Rakugi, Hiromi, Nakagami, Hironori (2022) Prevention of bleomycin-induced pulmonary fibrosis by a RANKL peptide in mice. Scientific Reports, 12 (1) doi:10.1038/s41598-022-16843-7
	Ju, Nan, Shimamura, Munehisa, Hayashi, Hiroki, Ikeda, Yuka, Yoshida, Shota, Nakamura, Ayumi, Morishita, Ryuichi, Rakugi, Hiromi, Nakagami, Hironori (2019) Preventative effects of the partial RANKL peptide MHP1-AcN in a mouse model of imiquimod-induced psoriasis. Scientific Reports, 9. doi:10.1038/s41598-019-51681-0
	Morikawa-Futamatsu, Kino, Adachi, Susumu, Maejima, Yasuhiro, Tamamori-Adachi, Mimi, Suzuki, Jun-ichi, Kitajima, Shigetaka, Ito, Hiroshi, Isobe, Mitsuaki (2006) HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1. Life Sciences, 79 (14) 1380-1390 doi:10.1016/j.lfs.2006.04.005
	Kitsuka, Takahiro, Shiraki, Aya, Oyama, Jun-ichi, Nakagami, Hironori, Tanaka, Atsushi, Node, Koichi (2022) A novel soluble epoxide hydrolase vaccine protects murine cardiac muscle against myocardial infarction. Scientific Reports, 12 (1) doi:10.1038/s41598-022-10641-x
	Shimamura, Munehisa, Nakagami, Hironori, Shimizu, Hideo, Mukai, Hideyuki, Watanabe, Ryosuke, Okuzono, Takeshi, Kawano, Tomohiro, Ikeda, Yuka, Hayashi, Hiroki, Yoshida, Shota, Ju, Nan, Mochizuki, Hideki, Morishita, Ryuichi (2018) Development of a novel RANKL-based peptide, microglial healing peptide1-AcN (MHP1-AcN), for treatment of ischemic stroke. Scientific Reports, 8. doi:10.1038/s41598-018-35898-z
	Kitsuka, Takahiro, Shiraki, Aya, Oyama, Jun‑ichi, Nakagami, Hironori, Tanaka, Atsushi, Node, Koichi (2022) Author Correction: A novel soluble epoxide hydrolase vaccine protects murine cardiac muscle against myocardial infarction. Scientific Reports, 12 (1) doi:10.1038/s41598-022-12232-2
	Yabumoto, Chizuru, Akazawa, Hiroshi, Yamamoto, Rie, Yano, Masamichi, Kudo-Sakamoto, Yoko, Sumida, Tomokazu, Kamo, Takehiro, Yagi, Hiroki, Shimizu, Yu, Saga-Kamo, Akiko, Naito, Atsuhiko T., Oka, Toru, Lee, Jong-Kook, Suzuki, Jun-ichi, Sakata, Yasushi, Uejima, Etsuko, Komuro, Issei (2015) Angiotensin II receptor blockade promotes repair of skeletal muscle through down-regulation of aging-promoting C1q expression. Scientific Reports, 5. doi:10.1038/srep14453